GD:NYSEGeneral Dynamics Corporation Analysis
Data as of 2026-04-05 - not real-time
$349.09
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
General Dynamics is trading at $349.09, just below its 20‑day SMA of 351.64 and comfortably above the 200‑day SMA of 334.48, indicating a neutral‑to‑slightly‑bullish medium‑term bias. The RSI sits at 48, suggesting the stock is not overbought, while the MACD histogram remains negative, hinting at short‑term bearish momentum. Fundamentally, the company posts a 7.8% revenue growth rate, a respectable 8.0% profit margin, and a solid free cash flow of $3.36 B, supporting its 1.74% dividend yield and a modest 38% payout ratio. Valuation metrics show a trailing P/E of 22.6 versus an industry average of 28.9, but a DCF‑derived fair value of $206 signals the market is pricing GD well above intrinsic estimates, implying a potential overvaluation. Recent material news highlights a $15.38 B Navy contract modification and a 30% surge in the 2025 backlog to $118 B, reinforcing near‑term revenue visibility. Analyst coverage has turned bullish, with Wells Fargo initiating an Overweight stance and a consensus 12.9% upside to the current price. Overall, the blend of strong cash generation, attractive dividend, and expanding defense backlog supports a buy recommendation, though the current price premium warrants caution.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Recent $15.38 B Navy contract modification boosting near‑term order flow
- Technical support near $337.8 and increasing volume indicating buying interest
- Neutral RSI and price above short‑term SMA suggesting limited downside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Revenue growth of 7.8% and expanding backlog to $118 B
- PE ratio below industry average and sustainable dividend yield
- Analyst consensus target median of $398 implying ~12% upside
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Diversified defense portfolio across aerospace, marine, combat and technology segments
- Stable government contract base with low beta (0.6) reducing market volatility
- Consistent free cash flow supporting dividend and potential share buybacks
Key Metrics & Analysis
Financial Health
Revenue Growth7.80%
Profit Margin8.01%
P/E Ratio22.6
ROE17.66%
ROA5.99%
Debt/Equity38.20
P/B Ratio3.7
Op. Cash Flow$5.1B
Free Cash Flow$3.4B
Industry P/E28.9
Technical Analysis
TrendNeutral
RSI48.0
Support$337.81
Resistance$364.40
MA 20$351.64
MA 50$353.52
MA 200$334.48
MACDBearish
VolumeIncreasing
Fear & Greed Index78.8
Valuation
Fair Value$205.96
Target Price$394.03
Upside/Downside12.87%
GradeOvervalued
TypeValue
Dividend Yield1.74%
Risk Assessment
Beta0.60
Volatility20.72%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.